Brief: Neurovive Pharmaceutical Q3 pre-tax loss narrows to SEK 13.2 mln

Abliva AB

21/11/2017 07:31

Nov 21 (Reuters) - NEUROVIVE PHARMACEUTICAL AB  NVP.ST  
    * Q3 PRE-TAX LOSS SEK 13.2 MILLION VERSUS LOSS SEK 34.3 
MILLION 
YEAR AGO 
 
Source text for Eikon:  ID:nWkr87Ljqx  
Further company coverage:  NVP.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))